Concepedia

Andrew D. Zelenetz

AD

289

Publications

31.8K

Citations

91

H-Index

1978

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

The University of Texas MD Anderson Cancer Center

Stanford University

Dana-Farber Cancer Institute

Andrew D. Zelenetz is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1978–2024

289

Publications

289

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

Roland Schmitz, George W. Wright, Da Wei Huang et al. · New England Journal of Medicine · 2018 · 2.2K citations · Full text

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

Richard R. Furman, Jeff P. Sharman, Steven Coutré et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elı́as Campo, Elaine S. Jaffe, James R. Cook et al. · Blood · 2022 · 1.4K citations · Full text

, , +22

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 934 citations · Full text

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

Kenneth R. Carson, Andrew M. Evens, Elizabeth Richey et al. · Blood · 2009 · 866 citations · Full text

Rows per page

1–5 of 289